Careful Selection
We like healthcare, curing or improving diseases in all areas, mainly with high medical need or fewest options, and AI driven transformations in all categories in healthcare including services
However, we are also 100% open to all other sectors and industries. As “value seekers” we build on new trends, better products or services, AI driven
Simplicity
& Selection
We have built companies from early, “ingredients and diamonds only” to where they are and perform today. We added financial considerations, skills, some management, ideas, AI and customer insights -hence, value enhancing strategies.
We nurture, keep it simple., execute and coach, track (and they us) with same tools as for our EDC investing decisions
Capital
First
Ethics driven has many aspects and also means that capital donors must come “first”
Our investors carry the risk of success and failure in the end – while management wants and needs to deliver
EDC also means we assure transparency, focus and execution – while we all work to common goals – as we all want to win together
Ethics
& Values
Success depends on many factors – attitude, team work, social skills, stamina, perseverance, coolness, courage, careful risk taking here and there, getting things done
Ethics, social values (Aristoteles, Kant) and honesty form the basis of all behaviour, deeds, decisions and actions in the end
About us
We are a team of biopharma commercial leaders, R&D, CRO & regulatory (Parexel), AI & IT, finance (Harvard, Kellogg EMBA) and law / IP specialists (EU, USA, Japan) with 25 years of experience working together
We come from different backgrounds, predominantly from business and science, medicine, biotechnology, IT, engineering,, data analysis, immunology. We added solid business, finance and leadership skills (Harvard, Kellogg, Stanford, St. Gallen), latest gen. AI and coding (Oxford, MIT, a lot of Stanford) and legal (Mannheim, St. Gallen, Hagen, Insead). We govern in a lean and smart way and provide all aspects of PE and cashflow driven finance (Harvard, Kellogg, St. Gallen). We operate a new, purely ethics driven, EDC model with clarity, finance focus, leadership, effective supervision and solid coaching to maximise our investments (few companies, 3-5 years horizon (4-8x) or roll over or longer term MBO, limited to 33% debt to equity ratio for commercial or pre-IPO)
Few things we’re really good at
We are good at combining break through technologies in break through areas to transform sectors. We like an optimal number of 2 to 3 break through technologies combined in a smart, AI driven way. This makes us unique, and our investments valuable and transformational.
Secondly, we are good at lifting valuations of companies with a business, R&D and financial, EBITA and EV, AI driven markets’ and customers’ approach. We do the same on costs for better focus and execution – and faster value creation. We go long on key drivers of value and short on risks and nice to haves. We like it simple, smart and lean. We hate complexity
We manage from a valuation driven (EV) investor’s perspective for success (EDC). We are “free cashflow enthusiasts” (EBITA, EV). We usually run all numbers again and again. We tend to leave upsides in valuations – to make sure our investments are truly in break through areas and transformational
For tracking, we create improved and gen. AI driven “business plans” and solid, free cashflow driven workbooks (EBITA). We model the expected “value path” of enterprise value (EV) over 15 years. It also serves as our “tracker” of EV, EBITA, and guides DCF decision making. PE principles form our “northstar” for valuation (EV) and performance equally (6 monthly) in all companies
The “how” differentiates our “what”. Ethics matter and we like high ethical standards (Aristoteles, Kant). From selection of companies to delivery (EDC)
We put investors front and center (EDC). We might offer several timepoints (2-3) to increase or reduce their stakes after 3-4 years. We are mainly equity financed and might go up to a maximum debt to equity ratio of 33% before commercialisation. Loyalty and stability come first while flexibility creates value
In our companies, we assure strong CEOs and teams, conduct financial reviews and provide updates to investors (6 monthly). We support with advisors and experts to accelerate our value creation (EV, EBITA) following our “value path”
On board composition, we love operational ex CEOs and C-suites with warm personalities. Gender and background neutral, they embrace diversity and add relevant, new perspectives. We are all humble, try to have fun and apply a sense of humour. Focus is key. We love break throughs while executing with ethical standards
Business Excellence
We love to create simple thus not trivial, break through business plans.
Financial Excellence
Optimising ROI of invested capital and reducing risks
in all aspects is our DNA.
Execution & Culture
“When the strategy is clear, execution becomes the new strategy.” Peter Drucker, 1965
Combine technologies & build the 1st global, purely (IO) cancer biopharma company in animal health in Switzerland
As an example, we have taken a deep breath and analysis into a technology in modern cancer therapy in humans and developed an AI driven, low-cost clinical approach to markets worldwide for horses, camels, dogs and even cats later on
The process has led to an AI driven, phase II/III clinical trial programme for EMA and FDA, MEA markets and the attraction of leading equine centers worldwide through personal networks.
We were also invited to open the company presentations in a major Life Sciences CEO Investors’ Conference in early 2025 – positive feedback from all three global regions. (incl. NA, APAC)
Leading Healthcare Commercial Company with products, patient centricity & patient services – with leading omni-channel & AI inclusion
Based on an experienced team from the 1st multi channel, big pharma company, we integrated AI selection and services to increase product usage by superior patient experiences. Both for launches and established, mature brands (data proven)
The company is “good to go” and to be internationally rolled out. We work with our first clients to be fully aligned for their long-term successes and plans
We like to hear from you:
We are good at putting breakthrough technologies, smart and ethical capital and internal AI technologies together, with strong management, boards and independent advisors. We are always open to discuss new opportunities in transformative sectors
breakthrough technologies
We love to hear from you in case you have a transformative or break through technology and want to build further with us, given same values and ethics (EDC)
smart and ethical investors and capital
We love to hear from you in case you want to invest in well set up, AI enhanced, risk mitigated, solid businesses, enterprises., given same values and ethics (EDC)
complementary skills, expert services, talent
We love to hear from you in case you want to work with us on well set up, risk mitigated, AI & solid businesses, enterprises., given same values and ethics (EDC)
New and AI driven
service providers
We love to hear from you in case you want to work with us on well set up, risk mitigated, AI & solid businesses, enterprises., given same values and ethics (EDC)
New and AI driven
product innovators
We love to hear from you in case you want to work with us on well set up, risk mitigated, AI & solid businesses, enterprises., given same values and ethics (EDC)
New, AI focused & AI interested investors
We love to hear from you in case you want to work with us on well set up, risk mitigated, AI & solid businesses, enterprises., given same values and ethics (EDC)
Our core team
We are a focused team and can count on 15-30 trusted, ethical, experienced “hands on” experts for insights, personal and professional advise, solid functional and risk assessments, for financial evaluations and trust their financial judgment
We can count on their honesty, loyalt and companionship, too
Pipeline of few projects
We have several new projects under assessment and in the pipeline that are exciting to us for their value increase & low risks, for being scalable, global, financially striking, as AI integrated products or services – all with breakthrough prospects and operating in fairly stable, healthy and leading sectors
Our opportunities are ROI, multiples driven companies mostly, latest AI and ethics and values driven for successful build up and team based scaling of operations – IF achievable in a simple way
Our Clients
Testimonials
The following customers and employees share thoughts and feelings working with us on from various roles or perspectives:
“I have seen the results of the IO product and the presentation at that investor conference. I was impressed how far they could go in just one year – and they go for global launch, exit or mid-term global profitability.”
Jane Morrison
“Wonderful to see the “dream – team” in Multi Channel of AZ coming together and building their “model” into an AI driven world. McKinsey and BCG all copied from them, no-one cracked that “AI nut”. What a great solution for millions of patients and big manufacturers, too. Services up, patient care up, costs down, impact and revenues for companies … up, up up. Bravo.”
Carola Montera
“I am amazed how open their thinking is with AI and their AI capabilities. They just embraced a boat and premium car local company and they’ll bring it to life it seems in Europe and Switzerland”
Michelle Stromberg
Contact us